Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zuogui granules is a traditional Chinese patent medicine (TCM) formulation traditionally used to nourish Kidney Yin. It is currently being evaluated in a Phase 2 clinical trial, led by Bing Shu, for its potential to improve bone metabolism and treat renal osteodystrophy in patients with chronic renal insufficiency. The formula is hypothesized to replenish Kidney Yin, which in TCM theory is essential for bone health and development, thereby addressing secondary osteoporosis and bone loss associated with renal failure. The formulation typically consists of a combination of herbal extracts including Rehmannia glutinosa, Dioscorea opposita, and Cornus officinalis, among others.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Zuogui granules.